TriSalus Life Sciences
TLSI
TLSI
68 hedge funds and large institutions have $219M invested in TriSalus Life Sciences in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 68 → 68 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
68
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.4M | |
| 2 | +$5.24M | |
| 3 | +$4.9M | |
| 4 |
Millennium Management
New York
|
+$4.81M |
| 5 |
IPCP
Iron Park Capital Partners
New York
|
+$4.24M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$2.88M | |
| 3 | -$2.37M | |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$2.22M |
| 5 |
AGC
Angelo Gordon & Co
New York
|
-$1.8M |